United Therapeutics Corporation UTHR

475.45 3.24 0.69% as of 25 Sep
Market cap
$20.3B
P/E
15.7×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
16.14 13.34 10.80 17.07 20.40 13.03 0.00 8.01 15.88 8.89
P/S ratio
6.78 5.54 4.57 6.42 5.76 4.52 2.66 2.91 3.87 3.94
P/FCF ratio
20.85 14.83 14.33 18.89 20.55 9.67 0.00 8.05 17.10 10.50
P/Operating CF
62.35 46.74 70.60 97.01 55.57 53.16 37.64 55.47 (77.92) 38.60
P/B ratio
3.04 2.47 1.78 2.59 2.45 1.98 1.39 1.70 3.18 3.41
Price to Tangible BV
3.09 2.52 1.81 2.62 2.48 2.07 1.47 1.81 3.25 3.47
EV/Sales
5.96 4.55 3.59 5.50 5.23 3.99 2.22 2.35 3.63 3.29
EV/EBITDA
12.02 9.02 6.74 10.33 14.56 9.21 0.00 4.54 7.40 4.81
EV/Operating CF
12.15 9.86 8.53 13.27 14.75 7.84 (15.60) 4.91 13.20 8.17
EV/FCF
18.32 12.16 11.24 16.17 18.68 8.54 (10.90) 6.49 16.01 8.76
Quick Ratio
5.83 4.80 4.07 8.91 6.97 6.16 3.54 5.75 2.75 3.81
Current Ratio
6.60 5.25 4.41 9.85 7.61 6.70 4.03 6.39 3.26 4.29
Net Debt/EBITDA
(1.85) (2.05) (1.85) (1.98) (1.87) (1.61) 4.49 (1.39) (0.80) (0.96)
Debt/Assets
0.00% 4.07% 9.77% 13.24% 15.48% 17.33% 21.72% 7.35% 8.68% 0.00%
Debt/Equity
0.00 0.05 0.12 0.17 0.20 0.24 0.31 0.09 0.12 0.00
Asset Turnover
0.42 0.40 0.35 0.35 0.34 0.35 0.40 0.52 0.66 0.71
Operating CF/Net income
1.17 1.11 0.99 1.10 1.26 1.47 1.98 1.32 1.13 0.90
Capex/Depreciation
(6.14) (3.40) (4.33) (2.71) (2.42) (1.14) (1.82) (5.14) (2.52) (1.20)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
19.71% 19.23% 18.27% 16.61% 12.94% 16.67% (3.75%) 24.10% 21.14% 41.50%
ROA
17.51% 16.45% 14.91% 12.97% 9.73% 12.07% (2.86%) 18.76% 16.06% 31.65%
ROIC
22.34% 24.75% 20.07% 22.20% 12.28% 15.72% (5.47%) 31.02% 35.76% 82.89%
Return on Tangible Assets
27.40% 27.42% 25.97% 18.66% 17.00% 19.99% (4.88%) 26.89% 26.98% 45.13%
Average Days of Receivables
40.16 35.43 43.74 41.55 43.03 38.73 38.14 39.40 62.85 48.97
Research and Development Expense of Revenue
17.28% 16.72% 17.53% 16.68% 32.04% 24.12% 81.63% 21.99% 15.34% 9.23%
Selling, General and Administrative Expense of Revenue
23.75% 24.66% 20.50% 24.90% 27.71% 28.58% 23.21% 16.33% 19.13% 19.81%
Intangible Assets out of Total Assets
0.01 0.02 0.02 0.01 0.01 0.03 0.04 0.05 0.02 0.01
Share Based Compensation of Revenue
4.64% 5.00% 1.68% 5.52% 8.22% 11.04% 3.13% (1.62%) 4.26% 0.76%
Graham Net Nets
0.14 0.19 0.22 0.17 0.11 0.14 0.19 0.24 0.10 0.15
Graham Number
329.81 291.28 246.16 194.87 144.95 141.90 0.00 140.06 101.42 124.12
Earnings Yield
6.19% 7.50% 9.26% 5.86% 4.90% 7.68% (2.75%) 12.49% 6.30% 11.25%
Free Cash Flow Yield
4.80% 6.74% 6.98% 5.30% 4.87% 10.34% (7.66%) 12.43% 5.85% 9.52%
Revenue per Share
71.84 63.66 49.73 42.56 37.54 33.56 33.08 37.42 39.21 36.50
Operating CF per Share
35.24 29.36 20.90 17.64 13.32 17.10 (4.72) 17.89 10.78 14.69
Capex per Share
(11.87) (5.45) (4.92) (3.05) (2.69) (1.29) (1.91) (4.24) (1.77) (0.87)
Free Cash Flow per Share
23.37 23.91 15.97 14.59 10.63 15.81 (6.63) 13.66 9.00 13.83
Cash per Share
65.92 72.28 63.98 62.39 43.00 41.52 33.92 32.55 21.08 23.99
Shareholders Equity per Share
160.19 142.57 127.88 105.42 88.17 76.81 63.48 64.11 47.77 42.27
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
160.19 142.57 127.88 105.42 88.17 76.81 63.48 64.11 47.77 42.27
Free Cash Flow
1,035.20 1,080.60 747.60 663.70 477.40 698.80 (290.30) 594.00 396.20 605.60
Working Capital
3,141.90 3,135.80 2,746.60 3,037.10 2,018.20 1,843.90 1,401.50 1,491.40 1,003.20 1,092.30
Capital Expenditures
(526.00) (246.50) (230.40) (138.80) (120.80) (56.90) (83.70) (184.40) (78.00) (38.00)
Net Current Asset Value
2,918.70 2,953.90 2,368.80 2,132.50 1,113.40 947.40 731.50 1,155.60 670.30 950.50
EV/EBIT
12.71 9.50 7.04 10.87 15.87 9.98 0.00 4.74 7.68 4.95
Capex to Sales
0.17 0.09 0.10 0.07 0.07 0.04 0.06 0.11 0.05 0.02
Net Profit Margin
41.94% 41.53% 42.31% 37.56% 28.23% 34.71% (7.21%) 36.20% 24.22% 44.64%
Price to Operating Income
14.46 11.58 8.98 12.69 17.45 11.30 0.00 5.88 8.20 5.94
Other line items
Depreciation/Fixed assets
0.05 0.06 0.05 0.06 0.06 0.07 0.06 0.05 0.06 0.06
Cash ROIC
(1.68%) 1.05% (0.70%) (0.70%) (2.73%) 0.40% (18.47%) 1.77% (2.18%) 5.32%
Accounts Receivable Turnover
10.11 10.31 9.32 9.24 9.47 9.61 8.86 6.89 6.74 7.85
Accounts Payable Turnover
0.92 0.96 0.98 0.75 0.68 0.64 0.75 1.18 0.77 0.70
Inventory Turnover
2.25 2.30 2.41 1.55 1.36 1.20 1.21 1.90 1.02 0.80
Average Days of Payables
463.37 406.01 422.41 553.52 520.24 631.41 460.60 305.12 590.84 523.15
Days of Inventory on Hand
173.86 186.09 158.47 245.58 279.49 292.07 289.89 185.53 372.60 502.06
Average Receivables
314.75 279.10 249.65 209.55 178.05 154.40 163.55 236.40 255.80 203.65
Average Payables
416.25 321.25 263.95 202.25 180.80 167.70 157.25 168.60 137.65 103.80
Average Inventory
170.50 134.85 106.90 97.90 90.15 89.95 97.20 104.45 103.95 90.65
Average Assets
7,622.00 7,265.50 6,605.75 5,606.80 4,892.05 4,264.20 3,657.20 3,140.20 2,602.50 2,255.00
Average Common Equity
6,770.10 6,214.40 5,390.75 4,377.80 3,677.05 3,087.80 2,784.50 2,445.20 1,976.55 1,719.95

Fold the line items

Columns are period end dates